Australia's Orthocell hits more than 5-year high on Singapore expansion deal

Orthocell

27/11/2024 02:49

** Orthocell  OCC.AX  jumps as much as 21.1% to A$0.775,
highest since May 9, 2019
    ** Stock logs biggest intraday pct jump since early October
    ** Biotech firm signs distributorship agreement with
Singapore-based Device Technologies Asia for exclusive
distribution of its nerve repair device Remplir
    ** OCC expects first sales of the device in first quarter of
2025
    ** Around 2.3 mln shares traded, 3.2x the 30-day avg
    ** Stock up ~87% YTD

 (Reporting by Nikita Maria Jino in Bengaluru)
 ((Nikita.Jino@thomsonreuters.com;))